Insider Shareholders with Direct Ownership of Aligos Therapeutics, Inc. (ALGS)
This section provides a comprehensive overview of the insiders with direct ownership of Aligos Therapeutics, Inc. (ALGS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Aligos Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
2,614,563 | 0 | 2,614,563 $101 Million | 1 |
Oct 20, 2020
Added 7.11%
|
|
Versant Venture Capital Vi, L.P.
> 10% Shareholder |
2,429,895 | 0 | 2,429,895 $93.6 Million | 1 |
Oct 20, 2020
Added 3.38%
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
1,906,191 | 0 | 1,906,191 $73.4 Million | 1 |
Oct 20, 2020
Added 23.05%
|
|
Lawrence Blatt
Chief Executive Officer |
610,277 | 0 | 1,847,575 $71.2 Million | 1 |
Oct 25, 2023
Added 24.83%
|
| 18,517 | 0 | 394,064 $15.2 Million | 1 |
Oct 20, 2020
Added 0.37%
|
|
| 183,083 | 0 | 183,083 $7.05 Million | 1 |
Oct 25, 2023
Added 50.0%
|
|
|
Thomas Woiwode
Director |
4,452 | 0 | 4,452 $171,491 | 2 |
Jun 11, 2021
Added 33.33%
|